BENSERAZIDE\LEVODOPA: 2,018 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,018
Total FAERS Reports
131 (6.5%)
Deaths Reported
1,153
Hospitalizations
2,018
As Primary/Secondary Suspect
120
Life-Threatening
85
Disabilities
Active Ingredient: BENSERAZIDE HYDROCHLORIDE\LEVODOPA ·
First Report: 19961101 · Latest Report: 20250725
What Are the Most Common BENSERAZIDE\LEVODOPA Side Effects?
#1 Most Reported
Fall
282 reports (14.0%)
#2 Most Reported
Dizziness
151 reports (7.5%)
#3 Most Reported
Hallucination
136 reports (6.7%)
All BENSERAZIDE\LEVODOPA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fall | 282 | 14.0% | 6 | 228 |
| Dizziness | 151 | 7.5% | 0 | 69 |
| Hallucination | 136 | 6.7% | 4 | 72 |
| Dyskinesia | 127 | 6.3% | 7 | 81 |
| General physical health deterioration | 127 | 6.3% | 7 | 117 |
| Parkinson's disease | 126 | 6.2% | 11 | 32 |
| Drug ineffective | 119 | 5.9% | 2 | 60 |
| Confusional state | 117 | 5.8% | 1 | 96 |
| Off label use | 112 | 5.6% | 3 | 59 |
| Somnolence | 110 | 5.5% | 6 | 52 |
| Hypotension | 105 | 5.2% | 3 | 79 |
| Nausea | 103 | 5.1% | 0 | 73 |
| Gait disturbance | 93 | 4.6% | 4 | 65 |
| Tremor | 85 | 4.2% | 2 | 59 |
| Vomiting | 84 | 4.2% | 12 | 42 |
| Condition aggravated | 83 | 4.1% | 17 | 56 |
| Fatigue | 72 | 3.6% | 5 | 28 |
| Hallucination, visual | 71 | 3.5% | 4 | 39 |
| Colitis microscopic | 69 | 3.4% | 0 | 6 |
| Constipation | 67 | 3.3% | 0 | 42 |
Who Reports BENSERAZIDE\LEVODOPA Side Effects? Age & Gender Data
Gender: 50.3% female, 49.7% male. Average age: 71.6 years. Most reports from: FR. View detailed demographics →
Is BENSERAZIDE\LEVODOPA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 6 | 0 | 2 |
| 2003 | 5 | 0 | 2 |
| 2005 | 4 | 0 | 2 |
| 2006 | 1 | 0 | 0 |
| 2007 | 3 | 2 | 2 |
| 2008 | 4 | 0 | 2 |
| 2009 | 5 | 0 | 5 |
| 2010 | 9 | 0 | 4 |
| 2011 | 3 | 0 | 3 |
| 2012 | 7 | 1 | 5 |
| 2013 | 13 | 1 | 7 |
| 2014 | 73 | 12 | 43 |
| 2015 | 118 | 10 | 84 |
| 2016 | 127 | 19 | 92 |
| 2017 | 153 | 5 | 91 |
| 2018 | 135 | 2 | 92 |
| 2019 | 131 | 5 | 89 |
| 2020 | 90 | 15 | 44 |
| 2021 | 108 | 18 | 76 |
| 2022 | 79 | 0 | 60 |
| 2023 | 94 | 4 | 68 |
| 2024 | 67 | 3 | 45 |
| 2025 | 31 | 1 | 20 |
What Is BENSERAZIDE\LEVODOPA Used For?
| Indication | Reports |
|---|---|
| Parkinson's disease | 915 |
| Product used for unknown indication | 656 |
| Parkinsonism | 113 |
| Restless legs syndrome | 29 |
| Resting tremor | 14 |
| Dystonia | 12 |
| Extrapyramidal disorder | 12 |
| Cognitive disorder | 11 |
| Dementia with lewy bodies | 11 |
| Multiple system atrophy | 10 |
BENSERAZIDE\LEVODOPA vs Alternatives: Which Is Safer?
BENSERAZIDE\LEVODOPA vs BENZALKONIUM
BENSERAZIDE\LEVODOPA vs BENZOCAINE
BENSERAZIDE\LEVODOPA vs BENZODIAZEPINE
BENSERAZIDE\LEVODOPA vs BENZONATATE
BENSERAZIDE\LEVODOPA vs BENZOYL PEROXIDE
BENSERAZIDE\LEVODOPA vs BENZOYL PEROXIDE\CLINDAMYCIN
BENSERAZIDE\LEVODOPA vs BENZOYLECGONINE
BENSERAZIDE\LEVODOPA vs BENZTROPINE
BENSERAZIDE\LEVODOPA vs BENZYDAMINE
BENSERAZIDE\LEVODOPA vs BENZYL ALCOHOL\ETANERCEPT
Official FDA Label for BENSERAZIDE\LEVODOPA
Official prescribing information from the FDA-approved drug label.